Appili Therapeutics Inc. announced a private placement that it has secured additional bridge financing in the amount of CAD 300,000 on April 26, 2024. The transaction included participation from new lender Bloom Burton & Co. Inc. The Bridge Loan evidenced by a grid promissory note in favor of the Lender pursuant to which further advances may be made from time to time as agreed to by the Company and the Lender, subject to any requisite regulatory and third party consents.

The loan bears 10% per annum. The principal amount of the Bridge Loan, together with all accrued and capitalized interest, will be due and repayable in full upon the earlier of April 26, 2025; and the occurrence of a Change of Control (as defined in the Bridge Loan) of the Company.